BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3670619)

  • 1. Hyperornithinemia, hyperammonemia, and homocitrullinuria: case report and biochemical study.
    Koike R; Fujimori K; Yuasa T; Miyatake T; Inoue I; Saheki T
    Neurology; 1987 Nov; 37(11):1813-5. PubMed ID: 3670619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation.
    Shih VE; Efron ML; Moser HW
    Am J Dis Child; 1969 Jan; 117(1):83-92. PubMed ID: 5782534
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on a case of HHH-syndrome (hyperammonemia, hyperornithinemia, homocitrullinuria).
    Hommes FA; Roesel RA; Metoki K; Hartlage PL; Dyken PR
    Neuropediatrics; 1986 Feb; 17(1):48-52. PubMed ID: 3960284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ornithine metabolism in cultured skin fibroblasts from patients with the syndrome of hyperornithinemia, hyperammonemia and homocitrullinuria.
    Shih VE; Mandell R; Herzfeld A
    Clin Chim Acta; 1982 Feb; 118(2-3):149-57. PubMed ID: 7055977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical analysis of decreased ornithine transport activity in the liver mitochondria from patients with hyperornithinemia, hyperammonemia and homocitrullinuria.
    Inoue I; Saheki T; Kayanuma K; Uono M; Nakajima M; Takeshita K; Koike R; Yuasa T; Miyatake T; Sakoda K
    Biochim Biophys Acta; 1988 Jan; 964(1):90-5. PubMed ID: 3334877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ornithine loading did not prevent induced hyperammonemia in a patient with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Simell O; Mackenzie S; Clow CL; Scriver CR
    Pediatr Res; 1985 Dec; 19(12):1283-7. PubMed ID: 4080446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements.
    Gordon BA; Gatfield DP; Haust MD
    Clin Invest Med; 1987 Jul; 10(4):329-36. PubMed ID: 3652557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, biochemical and ultrastructural study on the pathogenesis of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Nakajima M; Ishii S; Mito T; Takeshita K; Takashima S; Takakura H; Inoue I; Saheki T; Akiyoshi H; Ichihara K
    Brain Dev; 1988; 10(3):181-5. PubMed ID: 3407856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperornithinemia, hyperammonemia, and homocitrullinuria associated with decreased carbamyl phosphate synthetase I activity.
    Gatfield PD; Taller E; Wolfe DM; Haust MD
    Pediatr Res; 1975 May; 9(5):488-97. PubMed ID: 166348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.
    Zammarchi E; Ciani F; Pasquini E; Buonocore G; Shih VE; Donati MA
    J Pediatr; 1997 Sep; 131(3):440-3. PubMed ID: 9329423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of brain redox homeostasis caused by the major metabolites accumulating in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in vivo.
    Viegas CM; Tonin AM; Zanatta A; Seminotti B; Busanello EN; Fernandes CG; Moura AP; Leipnitz G; Wajner M
    Metab Brain Dis; 2012 Dec; 27(4):521-30. PubMed ID: 22798168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Episodic hyperammonemia in adult siblings with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
    Tuchman M; Knopman DS; Shih VE
    Arch Neurol; 1990 Oct; 47(10):1134-7. PubMed ID: 2222247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperornithinemia, hyperammonemia and homocitrullinuria due to a defect of mitochondrial membrane transport].
    Oyanagi K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):843-6. PubMed ID: 3270901
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the pathway from ornithine to proline in cultured skin fibroblasts with reference to the defect in hyperornithinaemia with hyperammonaemia and homocitrullinuria.
    Gray RG; Hill SE; Pollitt RJ
    J Inherit Metab Dis; 1983; 6(4):143-8. PubMed ID: 6422153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperornithinemia, hyperammonemia and homocitrullinuria syndrome in a family].
    Koike R; Fujimori K; Yuasa T; Miyatake T
    Rinsho Shinkeigaku; 1987 Apr; 27(4):465-71. PubMed ID: 3621746
    [No Abstract]   [Full Text] [Related]  

  • 16. Ciliated cultured dermal fibroblasts in a patient with hyperornithinemia, hyperammonemia and homocitrullinuria (HHH) syndrome.
    Haust MD
    Pathol Res Pract; 1995 Oct; 191(10):1062-5. PubMed ID: 8838382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective ornithine metabolism in the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria.
    Shih VE; Mandell R; Herzfeld A
    J Inherit Metab Dis; 1981; 4(2):95-6. PubMed ID: 6790865
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.
    Botschner J; Smith DW; Simell O; Scriver CR
    J Inherit Metab Dis; 1989; 12(1):33-40. PubMed ID: 2501580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new family affected by the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria.
    Rodes M; Ribes A; Pineda M; Alvarez L; Fabregas I; Fernandez Alvarez E; Coude FX; Grimber G
    J Inherit Metab Dis; 1987; 10(1):73-81. PubMed ID: 3106719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal urinary excretion of polyamines in HHH syndrome (hyperornithinemia associated with hyperammonemia and homocitrullinuria).
    Shimizu H; Maekawa K; Eto Y
    Brain Dev; 1990; 12(5):533-5. PubMed ID: 2288388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.